In a poster presentation, John Foreyt, at Baylor college of medicine reported that after one year, patients taking xenical inconjunction with a mildly hypocaloric diet lost significantly more weight than those taking placebo with the same diet. 57 percent of patients treated with xenicallost more than five percent of their initial weight vs. 34 percent of patients taking placebo. In the second year, significantly less weight was regained in those patients who continued taking Xenical than in patients who changed to Placebo. In fact, 35 percent regained there lost weight vs. placebo at 63 percent regain. Xenical also reduced the total cholesterol and LDL cholesterol and LDK cholesterol levels, as well as mean systolic and diastolic blood pressure, compared to diet alone. In a study presented by James Anderson, MD, obese patients who had lost more thaneight percent of there intitial body weight after 24 weeks on a hypocaloric diet, were randomizedto recieve Xenical 120 mg tid, 60 mg tid, 30 mg tid or placebo included with a special diet thathelps prevent weight regain instead of promoting weight loss. The results at the end of one year showed that 32 percent of the people who took xenical experienced regain, and a 56 percent regain of the patients taking placebo. Thus concluding xenical significantly helps patients to not regain there already lost weight. Dr.Anderson also found that patients taking xenical had much greater reductions in total cholesterol and LDL-cholesterol levels in comparison to diet alone. In another study on xenical, the experiment also lasted a year. Patients took 120mg ofxenical while eating a reduced calorie diet. The total amount of the daily calories contained 5around 30 percent fat. An average of around 10 percent of total body weight was lost per patient. Futhermore, 71 percent of the patients in the study maintained their weight loss. Most important,the test patients had their life-risk fac...
